Position in ESPR
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$0
+$0 QoQ
Shares Held
11,172
-50.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PSI Advisors, LLC holds $0 across 1 Drug Manufacturers - Specialty & Generic name. ESPR ranks #1 .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ESPR |
Esperion Therapeutics, Inc.
This page
|
11,172 | $0 |
All Filings in ESPR
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 11,172 | Shares | Sole | 2026-08-03 | |
| 2025-12-31 | — | 22,344 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | — | 13,500 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | — | 38,172 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | — | 13,500 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | — | 13,500 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | — | 13,500 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | — | 13,500 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | — | 17,000 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | — | 17,000 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | — | 6,500 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | — | 6,500 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | — | 6,500 | Shares | Sole | 2023-04-25 | |
| No filing history on record for this holder in this stock. | ||||||